1. Badylak SF, van Vleet JF. Sequential morphologic and clinicopathologic alterations in dogs with experimentally induced glucocorticoid hepatopathy. Am J Vet Res. 1981; 42:1310–1318.
2. Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, Kaplan S, Kiriş A, Orem C, Çelik S. Assessment of left ventricular diastolic function and Tei index by tissue Doppler imaging in patients with Cushing's syndrome. Echocardiography. 2008; 25:182–190.
3. Bayram NA, Ersoy R, Aydin C, Gul K, Keles T, Topaloglu O, Durmaz T, Bozkurt E, Cakir B. Assessment of left ventricular functions by tissue Doppler echocardiography in patients with Cushing's disease. J Endocrinol Invest. 2009; 32:248–252.
4. Cornell CC, Kittleson MD, Della Torre P, Häggström J, Lombard CW, Pedersen HD, Vollmar A, Wey A. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med. 2004; 18:311–321.
5. D'Hooge J, Heimdal A, Jamal F, Kukulski T, Bijnens B, Rademakers F, Hatle L, Suetens P, Sutherland GR. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr. 2000; 1:154–170.
6. Drighil A, Madias JE, Mathewson JW, El Mosalami H, El Badaoui N, Ramdani B, Bennis A. Haemodialysis: effects of acute decrease in preload on tissue Doppler imaging indices of systolic and diastolic function of the left and right ventricles. Eur J Echocardiogr. 2008; 9:530–535.
7. Edvardsen T, Skulstad H, Aakhus S, Urheim S, Ihlen H. Regional myocardial systolic function during acute myocardial ischemia assessed by strain Doppler echocardiography. J Am Coll Cardiol. 2001; 37:726–730.
8. Fallo F, Budano S, Sonino N, Muiesan ML, Agabiti-Rosei E, Boscaro M. Left ventricular structural characteristics in Cushing's syndrome. J Hum Hypertens. 1994; 8:509–513.
9. Glorioso N, Filigheddu F, Parpaglia PP, Soro A, Troffa C, Argiolas G, Mulatero P. 11β-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. Eur Heart J. 2005; 26:498–504.
10. Hattori T, Murase T, Iwase E, Takahashi K, Ohtake M, Tsuboi K, Ohtake M, Miyachi M, Murohara T, Nagata K. Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism. Nagoya J Med Sci. 2013; 75:81–92.
11. Hillis LD, Izquierdo C, Davis C, Brotherton S, Eberhart R, Roan PG, Willerson JT. Effect of various degrees of systemic arterial hypertension on acute canine myocardial ischemia. Am J Physiol. 1981; 240:H855–H861.
12. Misbach C, Gouni V, Tissier R, Trehiou-Sechi E, Petit AMP, Carlos Sampedrano C, Pouchelon JL, Chetboul V. Echocardiographic and tissue Doppler imaging alterations associated with spontaneous canine systemic hypertension. J Vet Intern Med. 2011; 25:1025–1035.
13. Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA, Mantero F, Fallo F. Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol. 2003; 41:2275–2279.
14. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997; 30:1527–1533.
15. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol. 1997; 30:8–18.
16. Oki T, Fukuda K, Tabata T, Mishiro Y, Yamada H, Abe M, Onose Y, Wakatsuki T, Iuchi A, Ito S. Effect of an acute increase in afterload on left ventricular regional wall motion velocity in healthy subjects. J Am Soc Echocardiogr. 1999; 12:476–483.
17. Pereira AM, Delgado V, Romijn JA, Smit JWA, Bax JJ, Feelders RA. Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome. Eur J Endocrinol. 2010; 162:331–340.
18. Peterson ME, Altszuler N, Nichols CE. Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism. Res Vet Sci. 1984; 36:177–182.
19. Pivonello R, Faggiano A, Lombardi G, Colao A. The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin North Am. 2005; 34:327–339.
20. Poulsen SH, Andersen NH, Ivarsen PI, Mogensen CE, Egeblad H. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent "isolated" diastolic dysfunction. J Am Soc Echocardiogr. 2003; 16:724–731.
21. Rivas-Gotz C, Manolios M, Thohan V, Naqueh SF. Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity. Am J Cardiol. 2003; 91:780–784.
22. Rosenfeld S, Marmorston J, Sobel H, White AE. Enhancement of experimental atherosclerosis by ACTH in the dog. Proc Soc Exp Biol Med. 1960; 103:83–86.
23. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American society of echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58:1072–1083.
24. Simak J, Keller L, Killich M, Hartmann K, Wess G. Color-coded longitudinal interventricular septal tissue velocity imaging, strain and strain rate in healthy Doberman Pinschers. J Vet Cardiol. 2011; 13:1–11.
25. Skulstad H, Andersen K, Edvardsen T, Rein KA, Tønnessen TI, Hol PK, Fosse E, Ihlen H. Detection of ischemia and new insight into left ventricular physiology by strain Doppler and tissue velocity imaging: assessment during coronary bypass operation of the beating heart. J Am Soc Echocardiogr. 2004; 17:1225–1233.
26. Smets P, Meyer E, Maddens B, Daminet S. Cushing's syndrome, glucocorticoids and the kidney. Gen Comp Endocrinol. 2010; 169:1–10.
27. Tidholm A, Ljungvall I, Höglund K, Westling AB, Häggström J. Tissue Doppler and strain imaging in dogs with myxomatous mitral valve disease in different stages of congestive heart failure. J Vet Intern Med. 2009; 23:1197–1207.
28. Young MJ, Moussa L, Dilley R, Funder JW. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11β-hydroxysteroid dehydrogenase inactivation. Endocrinology. 2003; 144:1121–1125.